These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32014424)

  • 1. DDX11-AS1 contributes to osteosarcoma progression via stabilizing DDX11.
    Zhang H; Lin J; Chen J; Gu W; Mao Y; Wang H; Zhang Y; Liu W
    Life Sci; 2020 Aug; 254():117392. PubMed ID: 32014424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA DDX11-AS1 facilitates gastric cancer progression by regulating miR-873-5p/SPC18 axis.
    Ren Z; Liu X; Si Y; Yang D
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):572-583. PubMed ID: 32054332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway.
    Wan T; Zheng J; Yao R; Yang S; Zheng W; Zhou P
    Ann Hepatol; 2021; 20():100258. PubMed ID: 32961346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA DDX11-AS1 epigenetically represses LATS2 by interacting with EZH2 and DNMT1 in hepatocellular carcinoma.
    Li Y; Zhuang W; Huang M; Li X
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1051-1057. PubMed ID: 31097223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long non-coding RNA DDX11-AS1 facilitates cell progression and oxaliplatin resistance via regulating miR-326/IRS1 axis in gastric cancer.
    Song W; Qian Y; Zhang MH; Wang H; Wen X; Yang XZ; Dai WJ
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3049-3061. PubMed ID: 32271422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA DDX11-AS1 promotes cell growth, migration and invasion through regulating epithelial-mesenchymal transition in breast cancer.
    Xi X; Yang F; Ding Z; Zhuang H; Yuan H
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):40-44. PubMed ID: 38678629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SP1-mediated upregulation of lncRNA LMCD1-AS1 functions a ceRNA for miR-106b-5p to facilitate osteosarcoma progression.
    He JW; Li DJ; Zhou JH; Zhu YL; Yu BQ
    Biochem Biophys Res Commun; 2020 Jun; 526(3):670-677. PubMed ID: 32248969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA DDX11-AS1 Promotes Chemoresistance through LIN28A-Mediated ATG12 mRNA Stabilization in Breast Cancer.
    Si X; Zhang G; Li M; Yao M; Shi X; Dong Z; Gao S
    Pharmacology; 2023; 108(1):61-73. PubMed ID: 36382664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis.
    Cui H; Zhao J
    J Cell Biochem; 2020 Mar; 121(3):2284-2293. PubMed ID: 31680323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA
    Chen D; Chen J; Gao J; Zhang Y; Ma Y; Wei W; Wei Y
    Cancer Biother Radiopharm; 2020 Jun; 35(5):319-328. PubMed ID: 32412777
    [No Abstract]   [Full Text] [Related]  

  • 11. DDX11-AS1exacerbates bladder cancer progression by enhancing CDK6 expression via suppressing miR-499b-5p.
    Li Q; Wang S; Wu Z; Liu Y
    Biomed Pharmacother; 2020 Jul; 127():110164. PubMed ID: 32422563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway.
    Shi D; Wu F; Mu S; Hu B; Zhong B; Gao F; Qing X; Liu J; Zhang Z; Shao Z
    J Exp Clin Cancer Res; 2019 Aug; 38(1):375. PubMed ID: 31443665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
    Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
    J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Landscape analysis of lncRNAs shows that DDX11-AS1 promotes cell-cycle progression in liver cancer through the PARP1/p53 axis.
    Xu M; Zhao X; Zhao S; Yang Z; Yuan W; Han H; Zhang B; Zhou L; Zheng S; Li MD
    Cancer Lett; 2021 Nov; 520():282-294. PubMed ID: 34371129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA DDX11-AS1: a novel oncogene in human cancer.
    Feng Y; Wu M; Hu S; Peng X; Chen F
    Hum Cell; 2020 Oct; 33(4):946-953. PubMed ID: 32772230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DSCAM-AS1 accelerates cell proliferation and migration in osteosarcoma through miR-186-5p/GPRC5A signaling.
    Ning Y; Bai Z
    Cancer Biomark; 2021; 30(1):29-39. PubMed ID: 32865178
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Luo Y; Tao H; Jin L; Xiang W; Guo W
    Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
    [No Abstract]   [Full Text] [Related]  

  • 18. LncRNA DDX11-AS1 Exerts Oncogenic Roles in Glioma Through Regulating miR-499b-5p/RWDD4 Axis.
    Zheng Y; Xie J; Xu X; Yang X; Zhou Y; Yao Q; Xiong Y
    Onco Targets Ther; 2021; 14():157-164. PubMed ID: 33447057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA DDX11-AS1 induced by YY1 accelerates colorectal cancer progression through targeting miR-873/CLDN7 axis.
    Tian JB; Cao L; Dong GL
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5714-5729. PubMed ID: 31298324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA DSCAM-AS1 upregulates
    Zhang S; Ding L; Gao F; Fan H
    Biochem Cell Biol; 2020 Oct; 98(5):600-611. PubMed ID: 32379981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.